Navigating the Latest Options for the Treatment of CKD in T2D

Download All
In this series of microlearning modules, expert faculty provide insight on new evidence and treatment for chronic kidney disease in type 2 diabetes to improve kidney and cardiovascular outcomes.
Vivian A. Fonseca, MD, FRCP

Individualizing Management in T2D with CKD

In this microlearning module, an expert faculty provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.

Vivian A. Fonseca, MD, FRCP Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: September 21, 2022 Expired: September 20, 2023

A leading expert provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.

Released: September 21, 2022

Dr Vivian Fonseca provides insights on how to tailor the management of type 2 diabetes (T2D) and chronic kidney disease (CKD) for your individual patients, including treatment recommendations for high-risk patients and those with concurrent cardiovascular disease.

Vivian A. Fonseca, MD, FRCP Released: September 14, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
Bayer HealthCare Pharmaceuticals Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings